top of page

Our Team

At our laboratory, we are at the forefront of cutting-edge genetic analysis, utilizing NGS technology to deliver high-quality and comprehensive testing services. With a commitment to excellence and adherence to stringent CLIA and CAP accreditation standards, we provide reliable and accurate results that contribute to informed clinical decision-making

Our website serves as a comprehensive platform to introduce you to our state-of-the-art facility and showcase our expertise in NGS testing. As pioneers in genomic medicine, we offer a wide range of NGS-based assays, catering to various clinical needs, including genetic disorders, oncology, pharmacogenomics, and infectious diseases.

Our team of experienced scientists, bioinformaticians, and genetic counselors are dedicated to providing exceptional services and support throughout the testing process. We prioritize patient care and collaboration with healthcare providers, offering tailored testing solutions that address individual clinical requirements.

Doctor's Appointment

Workplace Testing

CLIA laboratory sequencing tests are a vital component of modern medicine, offering comprehensive genetic analysis that assists in diagnosing genetic disorders, guiding treatment decisions, and advancing our understanding of various diseases. These tests empower healthcare providers to deliver more personalized and effective care to patients based on their unique genetic makeup.

Our Tests


A Clinical Research Organization (CRO) is a specialized company or organization that provides a range of services to support and conduct clinical trials and research studies on behalf of pharmaceutical, biotechnology, medical device, and healthcare companies.

Clinical research organizations play a critical role in helping pharmaceutical and biotechnology companies conduct clinical trials efficiently, navigate regulatory requirements, and advance the development of new drugs and therapies. Their expertise and specialized services contribute to the safe and effective evaluation of new medical treatments.

bottom of page